These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17381079)

  • 1. Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters.
    Zhang J; Pettersson HI; Huitema C; Niu C; Yin J; James MN; Eltis LD; Vederas JC
    J Med Chem; 2007 Apr; 50(8):1850-64. PubMed ID: 17381079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and evaluation of keto-glutamine analogues as potent inhibitors of severe acute respiratory syndrome 3CLpro.
    Jain RP; Pettersson HI; Zhang J; Aull KD; Fortin PD; Huitema C; Eltis LD; Parrish JC; James MN; Wishart DS; Vederas JC
    J Med Chem; 2004 Dec; 47(25):6113-6. PubMed ID: 15566280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase.
    Zhang J; Huitema C; Niu C; Yin J; James MN; Eltis LD; Vederas JC
    Bioorg Chem; 2008 Oct; 36(5):229-40. PubMed ID: 18295820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors.
    Ghosh AK; Gong G; Grum-Tokars V; Mulhearn DC; Baker SC; Coughlin M; Prabhakar BS; Sleeman K; Johnson ME; Mesecar AD
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5684-8. PubMed ID: 18796354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors.
    Im I; Lee ES; Choi SJ; Lee JY; Kim YC
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3632-6. PubMed ID: 19464175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of trifluoromethyl ketones as inhibitors of SARS-CoV 3CL protease.
    Shao YM; Yang WB; Kuo TH; Tsai KC; Lin CH; Yang AS; Liang PH; Wong CH
    Bioorg Med Chem; 2008 Apr; 16(8):4652-60. PubMed ID: 18329272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New developments for the design, synthesis and biological evaluation of potent SARS-CoV 3CL(pro) inhibitors.
    Regnier T; Sarma D; Hidaka K; Bacha U; Freire E; Hayashi Y; Kiso Y
    Bioorg Med Chem Lett; 2009 May; 19(10):2722-7. PubMed ID: 19362479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors.
    Dragovich PS; Zhou R; Webber SE; Prins TJ; Kwok AK; Okano K; Fuhrman SA; Zalman LS; Maldonado FC; Brown EL; Meador JW; Patick AK; Ford CE; Brothers MA; Binford SL; Matthews DA; Ferre RA; Worland ST
    Bioorg Med Chem Lett; 2000 Jan; 10(1):45-8. PubMed ID: 10636240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action.
    Huitema C; Zhang J; Yin J; James MN; Vederas JC; Eltis LD
    Bioorg Med Chem; 2008 May; 16(10):5761-77. PubMed ID: 18407505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural variations in keto-glutamines for improved inhibition against hepatitis A virus 3C proteinase.
    Jain RP; Vederas JC
    Bioorg Med Chem Lett; 2004 Jul; 14(14):3655-8. PubMed ID: 15203137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics.
    Dragovich PS; Prins TJ; Zhou R; Fuhrman SA; Patick AK; Matthews DA; Ford CE; Meador JW; Ferre RA; Worland ST
    J Med Chem; 1999 Apr; 42(7):1203-12. PubMed ID: 10197964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
    Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
    Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Broad-spectrum inhibitors against 3C-like proteases of feline coronaviruses and feline caliciviruses.
    Kim Y; Shivanna V; Narayanan S; Prior AM; Weerasekara S; Hua DH; Kankanamalage AC; Groutas WC; Chang KO
    J Virol; 2015 May; 89(9):4942-50. PubMed ID: 25694593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
    Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
    J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors.
    Prior AM; Kim Y; Weerasekara S; Moroze M; Alliston KR; Uy RA; Groutas WC; Chang KO; Hua DH
    Bioorg Med Chem Lett; 2013 Dec; 23(23):6317-20. PubMed ID: 24125888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human rhinovirus 3C protease as a potential target for the development of antiviral agents.
    Wanga QM; Chen SH
    Curr Protein Pept Sci; 2007 Feb; 8(1):19-27. PubMed ID: 17305557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and evaluation of 3C protease inhibitors as anti-enterovirus 71 agents.
    Kuo CJ; Shie JJ; Fang JM; Yen GR; Hsu JT; Liu HG; Tseng SN; Chang SC; Lee CY; Shih SR; Liang PH
    Bioorg Med Chem; 2008 Aug; 16(15):7388-98. PubMed ID: 18583140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based design, synthesis, and evaluation of peptide-mimetic SARS 3CL protease inhibitors.
    Akaji K; Konno H; Mitsui H; Teruya K; Shimamoto Y; Hattori Y; Ozaki T; Kusunoki M; Sanjoh A
    J Med Chem; 2011 Dec; 54(23):7962-73. PubMed ID: 22014094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virtual screening of novel noncovalent inhibitors for SARS-CoV 3C-like proteinase.
    Liu Z; Huang C; Fan K; Wei P; Chen H; Liu S; Pei J; Shi L; Li B; Yang K; Liu Y; Lai L
    J Chem Inf Model; 2005; 45(1):10-17. PubMed ID: 15667124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A structural view of the inactivation of the SARS coronavirus main proteinase by benzotriazole esters.
    Verschueren KH; Pumpor K; Anemüller S; Chen S; Mesters JR; Hilgenfeld R
    Chem Biol; 2008 Jun; 15(6):597-606. PubMed ID: 18559270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.